Skip to main content
Hualan Biological Engineering Inc. logo

Hualan Biological Engineering Inc. — Investor Relations & Filings

Ticker · 002007 ISIN · CNE000001JN8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,527 across all filing types
Latest filing 2014-04-17 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002007

About Hualan Biological Engineering Inc.

https://www.hualanbio.com

Hualan Biological Engineering Inc. is a biopharmaceutical enterprise specializing in the research, development, production, and commercialization of blood products and vaccines. The company’s portfolio is divided into two primary segments: plasma-derived therapeutics and viral vaccines. Key blood products include human albumin, intravenous immunoglobulin (IVIG), human coagulation factor VIII, and prothrombin complex. In the vaccine sector, the company produces seasonal influenza vaccines, including quadrivalent formulations, as well as hepatitis B and rabies vaccines. Hualan Biological Engineering operates advanced manufacturing facilities and plasma collection centers, focusing on high-quality standards and technological innovation in recombinant protein drugs and monoclonal antibodies to address critical medical needs in immunology, hematology, and infectious disease prevention.

Recent filings

Filing Released Lang Actions
独立董事候选人声明（田莉军）
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of a company, affirming compliance with various legal and regulatory requirements for the position. It includes statements about qualifications, independence, and adherence to regulatory rules, but does not contain financial data, earnings, or report content. It is not an annual report, earnings release, or any financial report. It is also not a simple announcement or certification but a formal declaration related to board/management information, specifically about a director candidate's qualifications and independence. Therefore, it fits best under Board/Management Information (MANG). The document length and content support this classification with high confidence.
2014-04-17 Chinese
独立董事提名人声明（一）
Board/Management Information Classification · 95% confidence The document is a formal statement from the board of directors nominating an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with regulatory requirements, and independence criteria. There are no financial statements, earnings data, or report attachments. The content focuses on board/management information, specifically the nomination of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length is moderate and contains detailed disclosures about the nominee, not just an announcement or a brief notice, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2014-04-17 Chinese
关于控股子公司取得吸附无细胞百白破联合疫苗临床试验批件的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (493 characters) regarding the approval of a clinical trial permit for a vaccine by a subsidiary of the company. It contains no financial data, no detailed report, and no mention of financial results or management changes. It is an official disclosure about a regulatory approval event. The document is not a report itself but an announcement of a regulatory event related to clinical trials. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2014-04-01 Chinese
关于举行2013年年度报告网上说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about holding an online explanation meeting for the 2013 annual report. It specifies the date and time of the meeting and invites investors to participate via an online platform. The document does not contain the annual report itself or detailed financial data, but rather informs about a presentation related to the annual report. This fits the definition of an Investor Presentation (IP) as it focuses on explaining financial results and company information to investors.
2014-04-01 Chinese
2013年度社会责任报告书
Environmental & Social Information Classification · 100% confidence The document is titled as a "2013 Annual Social Responsibility Report" of 华兰生物工程股份有限公司. It extensively discusses the company's social responsibility activities, including employee welfare, environmental protection, stakeholder engagement, and community contributions. The content focuses on Environmental, Social, and Governance (ESG) factors and the company's sustainability efforts. There is no indication of financial statements, audit opinions, or regulatory filings typical of annual or interim financial reports. The document length (8878 characters) and detailed narrative confirm it is a full report rather than a brief announcement. Therefore, the document fits the category of Environmental & Social Information (SR).
2014-03-27 Chinese
独立董事2013年度述职报告（李德新）
Audit Report / Information Classification · 95% confidence The document is a detailed report by an independent director of 华兰生物工程股份有限公司 for the year 2013. It includes the director's attendance at meetings, independent opinions on various company matters such as related party transactions, external guarantees, internal control evaluation, appointment of auditors, investment and financing activities, stock incentive plans, and protection of investor rights. The document references compliance with Chinese securities regulations and company governance rules. It is a comprehensive narrative of the independent director's duties and opinions over the fiscal year 2013, which aligns with the nature of an Audit Report / Information document, as it focuses on audit-related opinions, internal controls, and regulatory compliance rather than being a full annual report or other types of filings. The length and detail confirm it is not a brief announcement or certification but a substantive report. Therefore, the best fitting category is Audit Report / Information (AR). FY 2013
2014-03-25 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.